Attention-Deficit Hyperactivity Disorder (ADHD)
Mental Health
Attention-Deficit Hyperactivity Disorder (ADHD) is treated with 26 medications in our database, including Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, Lisdexamfetamine Dimesylate, Methylphenidate Hydrochloride, Atomoxetine, MYDAYIS, and 21 more. 17 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Teva Pharmaceuticals, Takeda, Novartis, Eli Lilly, Arbor and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Attention-Deficit Hyperactivity Disorder (ADHD) treatment below.
What help exists for Attention-Deficit Hyperactivity Disorder (ADHD)
23
drugs indexed
6
with copay cards
7
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Attention-Deficit Hyperactivity Disorder (ADHD)
23 totalDextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate Β· Teva Pharmaceuticals
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
ππCotempla XR-ODT
Methylphenidate Β· Aytu
DEXMETHYLPHENIDATE HYDROCHLORIDE
Dexmethylphenidate Hydrochloride
Amphetamine
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE Β· Arbor Pharmaceuticals
Atomoxetine
Atomoxetine Β· Eli Lilly
πDaytrana
methylphenidate Β· Noven
Evekeo
Amphetamine Sulfate Β· Arbor
LISDEXAMFETAMINE DIMESYLATE
Lisdexamfetamine Β· Takeda
Guanfacine Extended-Release
guanfacine Β· Takeda
ππAdzenys XR-ODT
Amphetamine Β· Aytu
Methylphenidate
methylphenidate hydrochloride
ππQuillivant XR
methylphenidate hydrochloride Β· Tris
ππMethylphenidate HCl
Methylphenidate HCl
ππDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE Β· Teva Pharmaceuticals
MYDAYIS
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE Β· Takeda
Amphetamine Extended-Release
Amphetamine Extended-Release Β· Takeda
DEXTROAMPHETAMINE SULFATE
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE
ππDexmethylphenidate Hydrochloride Extended-Release
dexmethylphenidate hydrochloride
Amphetamine Sulfate
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE Β· Arbor
Methylin
Methylphenidate Hydrochloride Β· Mallinckrodt
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Β· Takeda
DEXEDRINE SPANSULE
dextroamphetamine sulfate Β· Amedra
π = copay card Β· π = patient assistance program
Prior authorization patterns for Attention-Deficit Hyperactivity Disorder (ADHD) drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 25 PA rules for Attention-Deficit Hyperactivity Disorder (ADHD) drugs. View individual drug pages for complete PA detail.